Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.

@article{Barbieri2013ClinicalSO,
  title={Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.},
  author={Alberto Barbieri and E Giuliani and Chiara Carone and Filippo Pederzoli and Giovanna Mascheroni and Giuseppina Greco and Claudio G Stucchi and Susanna Genedani},
  journal={Minerva anestesiologica},
  year={2013},
  volume={79 7},
  pages={
          750-7
        }
}
BACKGROUND Stroke is a leading cause of long-term morbidity and mortality affecting several hundred-thousand people annually in the Western Countries. Various panels of biomarkers of neural damage have been developed and validated. The primary objective of this investigation was to measure the correlation between the clinical severity of stroke and the serum/plasma concentrations of neural damage biomarkers. METHODS A prospective investigation was conducted on a panel of biomarkers composed… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Preva - lence of Stroke – United States , 2006 - 2010

DZ Wang, JA Rose, DS Honings, DJ Garwacki, JC Milbrandt
Morb Mortal Wkly Rep • 2012

: The Biomarker Rapid Assessment in Ischemic Injury ( BRAIN ) Study

JW Elting, AE deJager, +3 authors J vanderNaalt
2009